Cytoplasmic GpIIb-IIIa and Cytokine Secretion by Blasts in a Case of Megakaryoblastic Transformation of Essential Thrombocythemia

References

• Fialkow P. J., Faguet G. B., Jacobson R. J., Vaidya K., Murphy S. Evidence that essential thrombocythemia is a clonal disorder with origin in a multipotent stem cell. Blood 1981; 58: 916–919
   PubMed Web of Science ®Google Scholar
• Bellucci S., Janvier M., Tobelem G., Flandrin G., Chazpach Y., Berger R., Boiron M. Essential thrombocythemias. Clinical, evolutionary and biological data. Cancer 1986; 58: 2240–2247
   Web of Science ®Google Scholar
• Lai J. L., Fenaux P., Zandecki M., Savary J. B., Es-tienne M. H., Jouet J. P., Bauters F., Deminatti M. Promyelocytic blast crisis of philadelphia-positive thrombocythemia with translocations (9, 22) and (15;17). Cancer Genet. Cytogenei. 1987; 29: 311–314
   PubMed Web of Science ®Google Scholar
• Paietta E., Rosen N., Roberts M., Papenhausen P., Wiernick P. H. Philadelphia chromosome positive essential thrombocythemia evolving into lymphoid blast crisis. Cancer Genet. Cytogenet. 1987; 25: 227–231
   PubMed Web of Science ®Google Scholar
• Toh B. T., Gregory S. A., Knospe W. H. Acute leukemia following treatment of polycythemia vera and essential thrombocythemia with uracil mustard. Am. J. Hema-tol. 1988; 28: 58
   PubMed Web of Science ®Google Scholar
• Toh T. B., Knospe W. H., Gregory S. A. Mye-lodysplastic syndrome and secondary acute leukemia after treatment of essential thrombocythemia with melphalan. Authors' reply. Am. J. Haematol. 1989; 30: 48
   Web of Science ®Google Scholar
• Ferrari A., Mazzucconi M. G., Chistolini A., Diverio D., Pasqualetti D., Zardo F., Enrici R. M., Mandelli F. Simultaneous occurrence of larinx carcinoma and acute blastic transformation in a patient with essential thrombocythemia. Haematologica 1990; 75: 488–489
   PubMedGoogle Scholar
• Asano Y., Naritomi Y., Kimura H., Maeda Y., Kusaba T., Yoshizawa S., Shiraishi G. Low-dose acla-rubicin in blastic transformation of essential thrombocythemia. Ann. Hematol. 1991; 62: 194–195
   PubMed Web of Science ®Google Scholar
• Vinti H., Taillan B., Pesce A., Michiels J. F., Bayle J., Cassuto J. P. Megakaryoblastic transformation of essential thrombocythemia, hypercalcemia and lytic bone lesions. Acta Haematol. 1990; 83: 53
   PubMed Web of Science ®Google Scholar
• Homma K., Nemoto K., Ohnishi Y., Kimura K. Blastic transformation of essential thrombocythemia. A case report. Acta Pathol. Jpn. 1989; 39: 670–676
   PubMedGoogle Scholar
• Frei-Lahr D., Barton J. C., Hoffman R., Burkett L. L., Prchal J. T. Blastic transformation of essential thrombocythemia: dual expression of myelomonoblastic/ megakaryoblastic phenotypes. Blood 1984; 63: 866–872
   PubMed Web of Science ®Google Scholar
• Michiels J. J., Prins M. E., Hagermeijer A., Brederoo P., van der Meulen J., van Vliet H. H., Abels J. Philadelphia chromosome-positive thrombocythemia and megakaryoblast leukemia. Am. J. Clin. Pathol. 1987; 88: 645–652
   PubMed Web of Science ®Google Scholar
• Kimura A., Fujimoto T., Inada T., Inamura N., Oguma N., Kajihara H., Mtasiwa D. M., Katoh O., Fujimura K., Kuramoto A. Blastic transformation in essential thrombocythemia. In vitro differentiation of blast cells into granulocytic, erythroid and megakaryocytic lineages. Cancer 1990; 65: 1538–1544
   PubMed Web of Science ®Google Scholar
• Ferrara F., Finizio O., De Rosa C., Mele G., Rametta V., Spada O. A., Del Vecchio L. T-cell leu-kemias: clinico-hematological report on six cases. Leuk. and lymph. 1991; 3: 217–222
   Web of Science ®Google Scholar
• Cordell J. L., Falini B., Erber W. N., Glosh A. K., Ab-dulaziz Z., Mac-Donald S., Pulford K. A. F., Stein H., Mason D. Y. Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes). J. Histochem. Cytochem 1984; 32: 219–224
   PubMed Web of Science ®Google Scholar
• Selleri C., Catatano L., De Rosa G., Fontana R., Notaro R., Rotoli B. Danazol: in vitro effects on human hemopoiesis and in vivo activity in hypoplastic and myelodys-plastic disorders. Eur. J. Haematol. 1991; 47: 197–203
   PubMed Web of Science ®Google Scholar
• Seabright M. A rapid banding technique for human chromosomes. Lancet 1971; 2: 971–972
   PubMed Web of Science ®Google Scholar
• Matsuda T., Hirano T., Kishimoto T. Establishment of an interleukin 6 (IL6)/B cell stimulatory factor 2-dependent cell line and preparation of anti-IL6 monoclonal antibodies. Eur. J. Immunol. 1988; 18: 951–955
   PubMed Web of Science ®Google Scholar
• Bennet J. M., Catovsky D., Daniel M. T., Flandrin G., Galton D. A. G., Gralnick H. R., Sultan C. Criteria for the diagnosis of acute leukemia of megakaryocyte lineage (M7). Ann. Intern. Med. 1985; 103: 469–462
   Google Scholar
• Sariban E., Oliver C., Corash L., Cossman J., Wang-Pen J., Jaffe E., Gralnick H. R., Poplack D. G. Acute megakaryoblastic leukemia in childhood. Cancer 1984; 198: 1423–1428
   Web of Science ®Google Scholar
• Berridge M. V., Ralph S. J., Tan A. S. Cell-lineage antigens of the stem cell-megakaryocyte-lineage are associated with the platelet Hb-HIa glycoprotein complex. Blood 1985; 66: 76–85
   PubMed Web of Science ®Google Scholar
• Griffin J. D., Lowenberg B. Clonogenic cells in acute myeloblastic leukemia. Blood 1989; 68: 1185–1195
   Google Scholar
• Murohashi I., Tohda S., Suzuki T., Nagata K., Yamash-ita Y., Nara N. Autocrine growth mechanism of the progenitors of blast cells in acute myeloblastic leukemia. Blood 1989; 74: 35–41
   PubMed Web of Science ®Google Scholar
• Hoffman R. Regulation of megakaryocytopoiesis. Blood 1989; 74: 1196–1212
   PubMed Web of Science ®Google Scholar
• Fuse A., Kakuda H., Shima Y., Van Damme J., Billiau A., Sato T. Interleukin 6, a possible autocrine growth and differentiation factor for the human megakaryocytic cell line, CMK. Br. J. Haematol. 1991; 77: 32–36
   PubMed Web of Science ®Google Scholar